Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply
- PMID: 39231355
- DOI: 10.1056/NEJMc2408733
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply
Comment on
-
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.N Engl J Med. 2024 Jun 13;390(22):2047-2060. doi: 10.1056/NEJMoa2401361. N Engl J Med. 2024. PMID: 38865660 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources